In an Emergency Setting, What Is the Best Intramuscular Pharmacological Treatment to Give to an Agitated Geriatric Patient?

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2022 Jul 1

PMID 35774721

Authors

Kevin Malone

Sall Saveen

Janice Hollier

Affiliations

Soon will be listed here.

Abstract

Herein, we describe an agitated geriatric patient who suffered an adverse outcome due to treatment for agitation in an emergency setting. This led to the prompt review of the current literature on best-practice medication to use in this population. After careful review, the authors recommend olanzapine as the first-line medication for agitation due to its lower risk-averse effect profile when compared to other medications used for this patient population.

Citing Articles

Characterizing PRN Use of Psychotropic Medications for Acute Agitation in Canadian Long-Term Care Residents with Dementia Before and During COVID-19.

Wang H, Kusumo R, Kiss A, Tennen G, Marotta G, Viaje S J Alzheimers Dis Rep. 2023; 7(1):575-587.

PMID: 37313488 PMC: 10259051. DOI: 10.3233/ADR-230009.

References

Markowitz J, Narasimhan M . Delirium and antipsychotics: a systematic review of epidemiology and somatic treatment options. Psychiatry (Edgmont). 2009; 5(10):29-36. PMC: 2695757. View

Chase P, Biros M . A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population. Acad Emerg Med. 2002; 9(12):1402-10. DOI: 10.1111/j.1553-2712.2002.tb01609.x. View

Maust D, Kim H, Seyfried L, Chiang C, Kavanagh J, Schneider L . Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry. 2015; 72(5):438-45. PMC: 4439579. DOI: 10.1001/jamapsychiatry.2014.3018. View

Marder S, Sorsaburu S, Dunayevich E, Karagianis J, Dawe I, Falk D . Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation. J Clin Psychiatry. 2010; 71(4):433-41. DOI: 10.4088/JCP.08m04411gry. View

Bach D, Bach M, Bohmer F, Fruhwald T, Grilc B . Reactivating occupational therapy: a method to improve cognitive performance in geriatric patients. Age Ageing. 1995; 24(3):222-6. DOI: 10.1093/ageing/24.3.222. View

Knol W, van Marum R, Jansen P, Souverein P, Schobben A, Egberts A . Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc. 2008; 56(4):661-6. DOI: 10.1111/j.1532-5415.2007.01625.x. View

Motov S, Drapkin J, Likourezos A, Doros J, Monfort R, Marshall J . Sub-dissociative dose ketamine administration for managing pain in the emergency department. World J Emerg Med. 2018; 9(4):249-255. PMC: 6117536. DOI: 10.5847/wjem.j.1920-8642.2018.04.002. View

Han J, Wilber S . Altered mental status in older patients in the emergency department. Clin Geriatr Med. 2012; 29(1):101-36. PMC: 3614410. DOI: 10.1016/j.cger.2012.09.005. View

Horowitz B, Bizovi K, Moreno R . Droperidol--behind the black box warning. Acad Emerg Med. 2002; 9(6):615-8. DOI: 10.1197/aemj.9.6.615. View

10.

Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V . A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry. 2002; 59(5):441-8. DOI: 10.1001/archpsyc.59.5.441. View

11.

Agostini J, Inouye S . Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients. Arch Intern Med. 2001; 161(17):2091-7. DOI: 10.1001/archinte.161.17.2091. View

12.

Clark W, Street J, Feldman P, Breier A . The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease. J Clin Psychiatry. 2001; 62(1):34-40. DOI: 10.4088/jcp.v62n0108. View

13.

Patel S, Crouse E, Levenson J . Evaluation of intramuscular olanzapine and ziprasidone in the medically ill. Ment Health Clin. 2021; 11(1):6-11. PMC: 7800324. DOI: 10.9740/mhc.2021.01.006. View

14.

Kennedy M, Koehl J, Shenvi C, Greenberg A, Zurek O, LaMantia M . The agitated older adult in the emergency department: a narrative review of common causes and management strategies. J Am Coll Emerg Physicians Open. 2020; 1(5):812-823. PMC: 7593470. DOI: 10.1002/emp2.12110. View

15.

Aarsland D, Larsen J, Lim N, Tandberg E . Olanzapine for psychosis in patients with Parkinson's disease with and without dementia. J Neuropsychiatry Clin Neurosci. 1999; 11(3):392-4. DOI: 10.1176/jnp.11.3.392. View

16.

Basciotta M, Zhou W, Ngo L, Donnino M, Marcantonio E, Herzig S . Antipsychotics and the Risk of Mortality or Cardiopulmonary Arrest in Hospitalized Adults. J Am Geriatr Soc. 2019; 68(3):544-550. PMC: 7155937. DOI: 10.1111/jgs.16246. View

17.

Bobes J, Rejas J, Garcia-Garcia M, Rico-Villademoros F, Garcia-Portilla M, Madrigal M . Frequency of Extrapyramidal Adverse Reactions in Schizophrenic Outpatients Treated with Risperidone, Olanzapine, Quetiapine or Haloperidol : Results of the EIRE Study. Clin Drug Investig. 2018; 22(9):609-622. DOI: 10.2165/00044011-200222090-00006. View

18.

Mocci G, Jimenez-Sanchez L, Adell A, Cortes R, Artigas F . Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action. Neuropharmacology. 2013; 79:49-58. DOI: 10.1016/j.neuropharm.2013.10.021. View

19.

Rayner A, OBrien J, Schoenbachler B, Shoenbachler B . Behavior disorders of dementia: recognition and treatment. Am Fam Physician. 2006; 73(4):647-52. View

20.

Motov S, Mann S, Drapkin J, Butt M, Likourezos A, Yetter E . Intravenous subdissociative-dose ketamine versus morphine for acute geriatric pain in the Emergency Department: A randomized controlled trial. Am J Emerg Med. 2018; 37(2):220-227. DOI: 10.1016/j.ajem.2018.05.030. View